Brett Favre tells Congress he’s been diagnosed with Parkinson’s

Brett Favre tells Congress he’s been diagnosed with Parkinson’s


Former NFL quarterback Brett Favre testifies before the House Ways and Means Committee at the Longworth House Office Building on September 24, 2024 in Washington, DC. 

Kevin Dietsch | Getty Images

Former Green Bay Packers quarterback Brett Favre said he’s been diagnosed with Parkinson’s, a stunning disclosure made to Congress on Tuesday while testifying about his potential misuse of taxpayer money.

Favre, appearing before the House Ways and Means Committee, has been accused of improperly using political connections to redirect public money to his alma mater and his own pocket.

“Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others, and I’m sure you’ll understand why it’s too late for me because I’ve recently been diagnosed with Parkinson’s,” Favre told lawmakers.

“This is also a cause dear to my heart. Recently, the doctor, running the company pleaded guilty to taking (public) money for his own use.”

Parkinson’s is a brain disorder that causes unintended or uncontrollable movements.

Symptoms, such as shaking and difficulty with balance and coordination, gradually worsen over time and often progress to difficulty walking and talking.

Favre was in Washington on Tuesday to answer questions about how he came into money from the federal Temporary Assistance for Needy Families (TANF) program.

The Hall of Fame QB improperly received program money for speaking engagements that he never made, according to a state auditor.

Favre is also accused of using his ties for former Gov. Phil Bryant to lobby for TANF funds to go to a new volleyball facility at his alma mater, the University of Southern Mississippi, where his daughter was a player.

Favre has not been criminally charged, but he is repaying some of the money.



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More